Larvol Cliniclarvol.hashnode.dev·Jul 26, 2024Randomized phase II stereotactic ablative radiation therapy (SABR) for metastatic unresected renal cell carcinomaThis project was supported by grants U10CA180822 (NRG Oncology SDMC), U24CA196067 (NRG Specimen Bank), U10CA180868 (NRG Oncology Operations), U24CA180803 (IROC) from the National Cancer Institute (NCI).” Background:The treatment landscape for patient...Discusshealthcare
Larvol Cliniclarvol.hashnode.dev·Jul 26, 2024Belantamab Mafodotin Exhibits No Evidence Of Immune Cell ImpairmentTopic: Myeloma and other monoclonal gammopathies — Biology & translational research Background:Belantamab mafodotin (belamaf) is a B-cell maturation antigen (BCMA) targeted antibody-drug-conjugatewith mechanisms of action against multiple myeloma (MM...Discussindia
Larvol Cliniclarvol.hashnode.dev·Jul 18, 2024An Investigational Study of Immunotherapy Combinations in Participants With Solid Cancers That Are Advanced or Have SpreadBrief Summary The purpose of this study is to demonstrate the safety and preliminary activity with triple combinations of relatlimab in combination with nivolumab and BMS-986205, or in combination with nivolumab and ipilimumab in immunotherapy-naive ...DiscussGoogle
Larvol Cliniclarvol.hashnode.dev·Jul 18, 2024TLR agonists polarize interferon responses in conjunction with dendritic cell vaccination in malignant glioma: a randomized phase II TrialAbstract In this randomized phase II clinical trial, we evaluated the effectiveness of adding the TLR agonists, poly-ICLC or resiquimod, to autologous tumor lysate-pulsed dendritic cell (ATL-DC) vaccination in patients with newly-diagnosed or recurre...Discussindia
